Ponvory Reduces Risk of Worsening Disability Over Placebo
Treatment with Ponvory (ponesimod) significantly reduces the risk of worsening disability or new relapses for people with relapsing forms of multiple sclerosis (MS) compared with a placebo, according to a new analysis funded by the therapy’s maker Janssen. The study,Ā “Comparative Efficacy of Relapsing Multiple Sclerosis Therapies:…